A previously unknown regulatory step during human immunodeficiency replication provides a potentially valuable new target for HIV/AIDS therapy, according to researchers.
A previously unknown regulatory step during human immunodeficiency replication provides a potentially valuable new target for HIV/AIDS therapy, according to researchers.